Basal insulin secretion capacity predicts the initial response and maximum levels of beta‐hydroxybutyrate during therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin, in relation to weight loss

AIMS: To investigate predictors of the initial response of beta‐hydroxybutyrate (BHB) and maximum BHB (max‐BHB) values during long‐term therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin (TOFO), and to explore the association of the initial elevation of BHB with subsequent clin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Obes Metab
Hauptverfasser: Sato, Yuichi, Nunoi, Kiyohide, Kaku, Kohei, Yoshida, Akihiro, Suganami, Hideki
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2019
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973158/
https://ncbi.nlm.nih.gov/pubmed/31608549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13890
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge